HistologiX, a leading Contract Research Organisation (CRO) offering Histology, IHC and Digital Pathology services, has appointed a new managing director to support its ambitious growth plans.
The Nottingham-based company, which forms part of the Intelligent Tissue Group (ITG) alongside Tissue Solutions Ltd, has internally promoted Barbara McManus as it seeks to build its service offering on a global platform.
Barbara, who joined Tissue Solutions Ltd as its UK Biosample Project Manager in 2018, brings more than twenty years of invaluable client management experience within the Life Sciences Sector to the role, having worked for both large multinationals and small business start-ups such as BioOutsource and MD Biosciences.
Developing a keen interest in science at an early age, Barbara studied Immunology and Pharmacology at the University of Strathclyde and developed her skill set working on various bioscience research projects across the UK.
Speaking about her appointment, Barbara McManus said:
“I’m looking forward to maximising the synergies between the companies within the Intelligent Tissue Group and working hard with a wonderful team of highly-skilled professionals, to tap into opportunities for expanding our services which will in turn maximise growth potential as we navigate the post-COVID-19 era.
“I am proud to join the HistologiX team who work to the highest levels of ethics and compliance to support the development of life-saving solutions in the drug development field and believe that my industry insights and hands-on experience with commercial customer service and client management, will enhance the service offering for our clients across the globe.”
Morag McFarlane, CEO at The Intelligent Tissue Group, said:
“Barbara’s appointment is richly deserved and will see her drive HistologiX forward as the company moves into the next phase of growth. Her steadfast contribution to the sector and extensive experience in client management will elevate our collective service offering and I look forward to seeing the next chapter unfold for the organisation under her leadership.”
HistologiX offers Histology, Immunohistochemistry and Digital Pathology services and solutions to clients, which include some of the world’s top pharmaceutical companies, along with innovative biotechnology companies which vary in size.
The company, that currently employs 20 staff, boasts a global customer base and provides world-leading solutions that accelerate ever-essential drug development and approval.
HistologiX and Tissue Solutions Ltd, a Glasgow-based virtual biobank, are part of the Intelligent Tissue Group – a dynamic company that offers a single point of access to a unique and tailored range of tissue procurement.
Together, HistologiX and Tissue Solutions are playing an integral part in helping to transform tissue into life-saving solutions.
Barbara McManus replaces Andrew Lawrence, who is retiring after holding the role of Managing Director for two years.